Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies
Redx Pharma Ltd
Redx Pharma Ltd
Taproot Health
National Institutes of Health Clinical Center (CC)
Sumitomo Pharma America, Inc.
University of Wisconsin, Madison
Xencor, Inc.
Augusta University
M.D. Anderson Cancer Center
Duke University
Stanford University
Jersey Shore University Medical Center
Third Military Medical University
National Institutes of Health Clinical Center (CC)
Samsung Medical Center
Stanford University
St. Luke's-Roosevelt Hospital Center
Indiana University
Federico II University